SMShashank Mishra

Shashank Mishra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shashank Mishra has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Solanum viarum Dunal: A Comprehensive Review of Morphology, Bioactive Constituents, and Medicinal Value

    by Shashank Mishra, Vishal Pandey, Saumya Pandey, Sunny Rathee, Sakshi Soni, Umesh K. Patil

    In this review, the medicinal use of the plant Solanum Viarum Dunal of the family Solanaceae was analysed. S. Viarum Dunal is observed to exhibit many pharmacological effects, such as anti-inflammatory, analgesic, anti-cancer, anti-microbial, and so forth. Many phytoconstituents, including steroidal glycosides like solaviasides and glycoalkaloids like solasodine, solasonine, and solamargine, have anti-inflammatory properties, flavonoids and phenolic alkaloids, etc., present mainly in fruit seeds, roots, stem, and leaves of the plant. S.Viarum Dunal, Anti-cancer activity is observed due to the presence of solasodine and other glycoalkaloids. The presence of flavonoids and polyphenolic substances results in the observation of anti-microbial and anti-pyretic properties. Different methods are developed for the extraction of phytoconstituents with different, also different methods of cultivation and tissue culture techniques developed are discussed in this review. This review aims to cover the knowledge regarding the pharmacological activity and medicinal use, pharmacognosy, and phytochemistry of different parts, such as fruits, leaves, seeds, and stems of the plant Solanum Viarum Dunal, belonging to the family Solanaceae.


  • Unlocking Toll-Like Receptors: Targeting Therapeutics for Respiratory Tract Infections and Inflammatory Disorders

    by Vishal Pandey, Debasis Sen, Sunny Rathee, Sakshi Soni, Shashank Mishra, Sanjay K. Jain, Umesh K. Patil

    The Toll-like Receptors (TLRs) family has significantly enhanced the understanding of innate immune responses by identifying and responding to various microbes or host-derived organisms. TLRs contribute to these responses by increasing the levels of cytokines, interleukins, and other inflammatory mediators through multiple pathways. Located both intracellularly and on the surface of various cells and tissues, including vascular smooth muscles (VSMs) and myocardium cells, TLRs play distinct roles in innate immune activation, such as recognizing pathogen-associated molecular patterns (PAMPs) and activating downstream signaling pathways. In the context of COVID-19, TLRs are critically involved in the pathophysiology by mediating excessive inflammatory responses that exacerbate disease severity, influencing both the acute phase and long-term outcomes. It has been observed that inflammatory diseases such as atherosclerosis, viral myocarditis, and other comorbidities associated with the spread of COVID-19 have increased, although the exact mechanisms remain not fully understood. Nonetheless, there is evidence of TLR-mediated increased pro-inflammatory signaling by different mechanisms in these diseases. This review explains the role of TLRs in various inflammatory diseases related to COVID-19, including viral myocarditis, acute lung infections, and atherosclerosis. Furthermore, the review discusses various herbal drugs, such as Platycodon grandiflorum, Acanthopanax senticosus, Scutellaria baicalensis Georgi, and Engelhardia roxburghiana, and their mechanisms of action on TLRs, including NF-κB, MyD88-dependent, MyD88-independent pathways, and Plasmacytoid DCs. Enhanced clarity on TLRs' specific contributions to COVID-19 pathophysiology and stronger evidence supporting herbal interventions targeting TLRs could improve the impact and applicability of these findings in clinical settings.